{"schema_version":"secwatch.filing_event.v1","accession":"0001847903-22-000118","form_type":"8-K","ticker":"CNTA","cik":"0001847903","company_name":"Centessa Pharmaceuticals plc","filed_at":"2022-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.710838+00:00","generated_at":"2026-06-20T23:36:38.351705+00:00","sec_items":["2.04"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Centessa obtains waiver for subsidiary name-change default on Note Purchase Agreement","bullets":["On Dec 22, 2022, Centessa entered a waiver with lenders for an Event of Default under the Oct 1, 2021 Note Purchase Agreement.","Default triggered by failure to provide prior written notice of a subsidiary's legal name change on Nov 22, 2022.","Waiver from Three Peaks Capital Solutions Aggregator Fund and Cocoon SA LLC (Oberland Capital affiliate) avoids loan acceleration and penalties.","Without waiver, lenders could have accelerated the loan under the Note Purchase Agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001847903-22-000118","json":"https://secwatch.observer/filing/0001847903-22-000118.json","markdown":"https://secwatch.observer/filing/0001847903-22-000118.md","text":"https://secwatch.observer/filing/0001847903-22-000118.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847903/000184790322000118/0001847903-22-000118-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847903/000184790322000118/cnta-20221122.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T23:36:38.351705+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}